New Stock News | BenQ Hospital's application to list on the Hong Kong Stock Exchange has failed. It is the largest private for-profit comprehensive hospital group in the East China region.

, BenQ Hospital Group Limited's Hong Kong Stock Exchange prospectus submitted on April 3, 2024 expired after 6 months on October 3. At the time of submission, CICC and Citigroup were its sponsors. According to the prospectus at the time of submission, BenQ Hospital Group, drawing on the advanced hospital operation and management experience in Taiwan, is a pioneer and leader in private for-profit comprehensive hospital groups in Mainland China. The company currently owns and operates two comprehensive hospitals. According to Frost & Sullivan data, based on medical service revenue generated in 2022, BenQ Hospital Group is the largest private for-profit comprehensive hospital group in the East China region, with revenue exceeding the combined total of the second and third places. In the same category, among all private for-profit comprehensive hospital groups nationwide, BenQ Hospital Group ranks fifth, and is the only one among the top five with all hospitals being tertiary hospitals. Based on the average revenue per registered bed in 2022, BenQ Hospital Group ranks first among all private for-profit comprehensive hospital groups in Mainland China. As of December 31, 2023, the total operating area of BenQ Hospital's two hospitals is approximately 380,000 square meters, with a total of 1,850 registered beds and a medical team of over 900 doctors, including 35 experts from Taiwan and overseas. In 2023, the outpatient visits of the company exceeded 2 million, with over 20,000 inpatient surgeries annually. BenQ Hospital has established two comprehensive hospitals, Nanjing BenQ Hospital and Suzhou BenQ Hospital. Financially, in the fiscal years of 2021, 2022, and 2023, the company achieved operating revenues of approximately RMB 2.224 billion, RMB 2.336 billion, and RMB 2.688 billion respectively. During the same period, the company's annual profits were approximately RMB 69.075 million, RMB 89.55 million, and RMB 167 million respectively.